Ponto Implantation Using a Minimally Invasive Surgical Technique
Evaluation of Clinical Performance of Ponto Implantation Using a Minimally Invasive Surgical Technique - a Prospective Multicentre Study
1 other identifier
interventional
52
4 countries
7
Brief Summary
This multi-centre study funded by Oticon Medical AB will be conducted at seven hospitals across Europe (UK, Sweden, Denmark and the Netherlands). In total, 50 adult patients with a hearing loss that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study. The purpose of the study is to investigate the rate of successful BAHS use after implantation of the Ponto implant system using a minimally invasive surgical technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2020
CompletedFirst Posted
Study publicly available on registry
October 28, 2020
CompletedStudy Start
First participant enrolled
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 26, 2023
CompletedResults Posted
Study results publicly available
January 29, 2026
CompletedJanuary 29, 2026
January 1, 2026
1.8 years
October 22, 2020
March 14, 2025
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Implants With Reliable Anchorage for a Sound Processor
The variables assessed to determine reliable anchorage in the study are implant survival and stability, skin reactions, skin overgrowth and pain preventing use of the sound processor. For a positive outcome of the primary endpoint (reliable anchorage), the implant should be in place and stable without any adverse skin reactions, skin overgrowth or pain preventing usage of the sound processor.
3 months after implant surgery
Secondary Outcomes (15)
Number of Implants With Reliable Anchorage for a Sound Processor
12 months after implant surgery
Implant Survival
12 months after implant surgery
Implant Stability
12 months after implant surgery
Holgers Score Distribution
9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits
Max Holgers Score
12 months after implant surgery
- +10 more secondary outcomes
Study Arms (1)
Single-arm
OTHERIn this single-arm study the patients will be undergoing a minimally invasive surgery after which they will re-visit the clinic at five occasions for follow-up visits (1-3 extra compared to routine clinical practice at the hospitals) and complete a quality of life-questinnaire three months after surgery.
Interventions
A quality of life-questionnaire is to be completed by the subjects at one occasion.
There are 1-3 additional follow-up visits after surgery (compared to the routine clinical practice of the surgeons/clinics).
The subjects will be implanted with a bone anchored hearing system using a minimally invasive surgery.
Eligibility Criteria
You may qualify if:
- years of age or older
- Patient indicated for surgical intervention with a bone anchored hearing system
- Signed informed consent
- Adequate bone quality to allow for a Ponto implant insertion, as judged by the investigator, and an expected bone thickness above 5 mm, where no complications during surgery are expected
- Skin thickness of 12 mm or less at the implant site
You may not qualify if:
- Patient undergoing re-implantation
- Patient who are unable or unwilling to follow investigational procedures/requirements, e.g. to complete quality of life scales
- Known condition or previous treatment that could jeopardize skin condition and wound healing over time as judged by the investigator (e.g. uncontrolled diabetes, previous radiotherapy in the area of interest)
- Known medical condition that contraindicate surgery as judged by the investigator
- Known and/or planned pregnancy at time of surgery
- Any other known condition that the investigator determines could interfere with compliance or investigation assessments
- Simultaneous participation in another clinical investigation with pharmaceutical and/or medical device which might cause interference with investigation participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oticon Medicallead
Study Sites (7)
Aalborg University Hospital
Aalborg, 9000, Denmark
Univerisity Medical Center Groningen
Groningen, Netherlands
Radboud University Medical Center
Nijmegen, 6525EX, Netherlands
Sahlgrenska University Hospital
Gothenburg, 413 46, Sweden
University Hospitals Birmingham NHS Foundation Trust
Birmingham, B15 2WB, United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7EH, United Kingdom
Related Publications (1)
Teunissen EM, Aukema TW, Banga R, Eeg-Olofsson M, Hol MKS, Hougaard DD, Tysome JR, Johansson ML, Svensson S, Powell HRF. Evaluation of Clinical Performance of Ponto Implantation Using a Minimally Invasive Surgical Technique-A Prospective Multicenter Study. Otol Neurotol. 2024 Oct 1;45(9):1037-1044. doi: 10.1097/MAO.0000000000004315. Epub 2024 Aug 26.
PMID: 39186326DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director of Clinical Affairs
- Organization
- Oticon Medical
Study Officials
- PRINCIPAL INVESTIGATOR
Harry Powell, MD
Guy's and St Thomas' NHS Foundation Trust
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2020
First Posted
October 28, 2020
Study Start
November 4, 2020
Primary Completion
August 9, 2022
Study Completion
April 26, 2023
Last Updated
January 29, 2026
Results First Posted
January 29, 2026
Record last verified: 2026-01